研究揭示 IDH 突变在 AML 不同年龄组中的预后意义。
Study Offers Insights on Prognostic Significance of IDH Mutations Across Age Groups in AML.
出版信息
Oncologist. 2021 Feb;26 Suppl 1(Suppl 1):S13-S14. doi: 10.1002/onco.13656. Epub 2020 Dec 28.
Abstract
A new analysis describes the prognostic significance of mutations across age groups in acute myeloid leukemia, with potential implications for ‐targeted therapy in patients with worse prognosis.
摘要
一项新的分析描述了急性髓系白血病中不同年龄组突变的预后意义，这可能对预后较差的患者的靶向治疗具有重要意义。
相似文献
1
Study Offers Insights on Prognostic Significance of IDH Mutations Across Age Groups in AML.研究揭示 IDH 突变在 AML 不同年龄组中的预后意义。
Oncologist. 2021 Feb;26 Suppl 1(Suppl 1):S13-S14. doi: 10.1002/onco.13656. Epub 2020 Dec 28.
2
[Research advances of IDH gene mutation and AML].[异柠檬酸脱氢酶（IDH）基因突变与急性髓系白血病的研究进展]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2014 Oct;22(5):1485-9. doi: 10.7534/j.issn.1009-2137.2014.05.058.
3
Isocitrate dehydrogenase (IDH) inhibition as treatment of myeloid malignancies: Progress and future directions.异柠檬酸脱氢酶（IDH）抑制作为治疗髓系恶性肿瘤的方法：进展与未来方向。
Pharmacol Ther. 2017 Sep;177:123-128. doi: 10.1016/j.pharmthera.2017.03.003. Epub 2017 Mar 14.
4
Correlation Between Isocitrate Dehydrogenase Gene Aberrations and Prognosis of Patients with Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis.异柠檬酸脱氢酶基因突变与急性髓系白血病患者预后的相关性：系统评价和荟萃分析。
Clin Cancer Res. 2017 Aug 1;23(15):4511-4522. doi: 10.1158/1078-0432.CCR-16-2628. Epub 2017 Feb 28.
5
Therapeutic targeting of isocitrate dehydrogenase mutant AML.异柠檬酸脱氢酶突变型急性髓系白血病的治疗靶点
Expert Opin Investig Drugs. 2017 May;26(5):525-530. doi: 10.1080/13543784.2017.1317745. Epub 2017 Apr 19.
6
Isocitrate dehydrogenase mutations in myeloid malignancies.髓系恶性肿瘤中的异柠檬酸脱氢酶突变
Leukemia. 2017 Feb;31(2):272-281. doi: 10.1038/leu.2016.275. Epub 2016 Oct 10.
7
IDH Inhibitors in AML-Promise and Pitfalls.IDH 抑制剂在 AML 中的应用：前景与挑战。
Curr Hematol Malig Rep. 2021 Apr;16(2):207-217. doi: 10.1007/s11899-021-00619-3. Epub 2021 Apr 30.
8
Combining Isocitrate Dehydrogenase Inhibitors With Existing Regimens in Acute Myeloid Leukemia: An Evolving Treatment Landscape.联合异柠檬酸脱氢酶抑制剂与现有的治疗方案治疗急性髓系白血病：不断发展的治疗领域。
Cancer J. 2022;28(1):21-28. doi: 10.1097/PPO.0000000000000570.
9
[IDH gene mutations and acute myeloid leukemia].
Zhonghua Xue Ye Xue Za Zhi. 2013 Mar;34(3):273-5. doi: 10.3760/cma.j.issn.0253-2727.2013.03.023.
10
IDH mutations in glioma and acute myeloid leukemia.IDH 突变在胶质瘤和急性髓系白血病中的作用。
Trends Mol Med. 2010 Sep;16(9):387-97. doi: 10.1016/j.molmed.2010.07.002. Epub 2010 Aug 5.
引用本文的文献
1
Granular acute lymphocytic leukemia : a case report and literature review.颗粒性急性淋巴细胞白血病：一例报告及文献复习
Discov Oncol. 2025 Aug 26;16(1):1629. doi: 10.1007/s12672-025-03449-4.
Zotero 插件